Europe Animal Model Market to Attain USD 3.5 Billion Valuation By 2027

September 14, 2021

According to the recent research report titled ‘Europe Animal Model Market Forecast 2027 By Application, By Animal Type, By Technology, By Use, By End-use, Research Report, Regional Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with Market Study Report, Europe animal model market is reckoned to amass USD 3.5 billion by the year 2027.

Increasing number of pharmaceutical research & development activities, and physiological similarities between animal and human are driving Europe animal model market.

Request sample copy of this Report:

Notably, scientists have uncovered significant anatomical and physiological similarities between humans and some animals, leading to the development of several procedures for inventing new medications and vaccinations. Animal models tailored to a certain disease are created in order to acquire valuable insight into the immune systems of animal species such as mice. This technique is both cost-effective and timesaving, making it a popular choice among researchers.

The COVID-19 pandemic posed as a boon for the industry, as it gave rise to development of new vaccines to combat the coronavirus's spread. Scientists have increasingly used animal models to test the efficacy of drugs created to fight this virus, on account of the similarities identified in the genomes of mice and humans.

Considering restraints, growing opposition on animal testing by various organizations, along with hefty cost of the process, and strict regulations & guidelines are anticipated to hamper the remuneration scope of Europe animal model industry.

Based on animal gamut, pigs segment is slated to grow substantially over the coming years. Pigs are thought to be one of the best animal models for evaluating the efficacy of medical devices and medications. CRISPR technology is used to modify their genes, which are then employed in various tests. Their anatomy, physiology, and genetic structure are quite similar to human beings, making it easier for researchers to predict the influence of a particular medication on the human immune system, further adding to their demand.

As per technology type, Europe animal model market share from embryonic stem cell injection segment is projected to register a CAGR of 5.7 % over 2021-2027. The growth can be credited to the significance of embryonic stem cell in life-saving therapies such as cell-replacement, which can be effective in treating severe diseases like breast and prostate cancer.  

Elaborating on application spectrum, production & quality control segment is predicted to witness stellar growth through 2027, attributable to the requirement of putting every new drug or vaccine through quality control test to determine its efficiency.

Major companies impacting Europe animal model market trends are Harbor Antibodies B.V., Crown Bioscience Inc., The Jackson Laboratory, Janvier Labs, Taconic Biosciences, PharmaLegacy Laboratories, genOway S.A., Envigo, and Charles River Laboratories International Inc.

Chat with us